XML 71 R43.htm IDEA: XBRL DOCUMENT v3.25.2
ACQUISITION - Narrative (Details)
$ / shares in Units, $ in Thousands
 5 Months Ended 12 Months Ended
Mar. 31, 2024
CAD ($)
Mar. 31, 2025
CAD ($)
Mar. 31, 2024
CAD ($)
Oct. 23, 2023
shares
patent_family
patent
application
$ / shares
Feb. 28, 2023
CAD ($)
Disclosure of detailed information about business combination [line items]          
Net loss for the year   $ (113,137) $ (78,080)    
Small Pharma Inc. ("Small Pharma")          
Disclosure of detailed information about business combination [line items]          
Ratio of common shares issued       0.634%  
Number of instruments or interests issued or issuable (in shares) | shares       2,130,138  
Unexercised stock options in subsidiary, compensation for cancellation (in CAD per share) | $ / shares       $ 0.001  
Number of active patent families | patent_family       17  
Number of pending patent applications | application       92  
Number of granted patents | patent       30  
Net loss for the year $ (1,666)        
Small Pharma Inc. ("Small Pharma") | Canada          
Disclosure of detailed information about business combination [line items]          
Loss carryforwards         $ 9,393
Small Pharma Inc. ("Small Pharma") | United Kingdom          
Disclosure of detailed information about business combination [line items]          
Loss carryforwards         $ 46,631